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Transfection of tubule cells with Fas ligand causes leukocyte Interstitial inflammation and fibrosis are prominent
apoptosis. features of all types of chronic renal disease [1]. Although
Background. Since the Fas/Fas Ligand (FasL) interaction is remarkable progress has been made in the past ten yearsrecognized as a major pathway of apoptosis in immune cells,
in understanding the pathogenesis of interstitial injury,we hypothesized that selective expression of FasL by tubular
cells (TC) may promote the resolution of interstitial inflamma- therapeutic strategies remain ineffective [2]. Recently,
tion by inducing apoptosis of infiltrating immune cells. In this the role of individual mediators, especially cytokines,
study, the effect of FasL transfection of rat TC on apoptosis has been explored extensively [3–5]. However, cytokine
of leukocytes was examined.
therapy is ineffective or only partially effective in pre-Methods. Rat tubule cells (NRK52E) were transfected with
venting interstitial injury, because of the complexities ofplasmids constructed using human and rat FasL (hFasL and
rFasL). The propensity of activated, transfected TC to undergo the redundant network of cytokines with overlapping
apoptosis was examined. Similarly, the effects of FasL transfec- and/or opposing effects on interstitial target cells. For
tion on apoptosis of Jurkat cells and activated leukocytes were example, whereas interleukin-4 (IL-4) and transformingassessed directly following co-culture for 12 hours and in a cell
growth factor- (TGF-) inhibit the functions of macro-insert system intended to assess the effects of soluble FasL.
phages and thereby limit interstitial inflammation, theyFas and FasL expression was assessed by flow cytometry and
apoptosis was examined using Annexin V staining and the also promote the proliferation of fibroblasts and thus
TUNEL method. aggravate interstitial fibrosis [6–8].
Results. Expression of FasL in TC was increased after FasL
Fas is a receptor for initiating apoptosis and Fas ligandtransfection. Transfected TC showed no detectable increase in
(FasL) a mediator for the delivery of death signals. FasLapoptosis following lipopolysaccharide (LPS) or tumor necro-
sis factor- (TNF-) activation. Jurkat cell apoptosis was in- induces apoptosis by binding to its receptor Fas. This
creased ninefold and eightfold after co-culture with TC trans- process has been recognized as the major pathway of
fected with hFasL and rFasL, respectively (67.0  12.1% and cell apoptosis for homeostasis of T cell numbers and60.1  8.8% vs. 6.7  1.8% with un-transfected TC, P 
maintenance of immunological privilege [9]. The Fas/0.01). Similarly, apoptosis of activated leukocytes was increased
FasL pathway has been utilized as a potential therapeuticfourfold by co-culture (26.8  4.9% vs. 6.7  2.0% with un-
transfected TC, P  0.01). Leukocyte apoptosis also was in- approach for cancer and autoimmune disorders [10, 11].
creased in an insert culture system (18.2 4.4% vs. 5.8 2.3% Attempts to resolve inflammation by manipulation of
with un- transfected TC, P 0.01). No increase of TC apoptosis
Fas/FasL interactions have been made in vivo in a murinewas detected in any of the co-culture experiments.
asthma model and in vitro on endothelium to inhibitConclusion. Enhanced expression of FasL by TC is capable
of inducing apoptosis of activated leukocytes, without evidence leukocyte extravasation [12, 13]. However, the potential
for increased susceptibility to apoptosis of the transfected cells efficacy of enhancing the Fas/FasL pathway to prevent
themselves. This suggests a potential role for this approach in renal interstitial inflammation and fibrosis has not been
the limitation and resolution of renal tubulointerstitial in-
tested. Human tubule cells (TC) expressed both Fas andflammation.
FasL, but they appear to be resistant to Fas-mediated
apoptosis [14]. On the other hand, it has been reported
Key words: Fas/FasL, tubule cell, renal tubulointerstitial, cells inflam- that activated leukocytes and fibroblasts are sensitive to
mation, cell death, chronic renal disease, fibroblasts. Fas-induced death [15, 16], and Fas-sensitized lympho-
Received for publication June 30, 2000
cytes can be killed by tubular cells via the Fas-FasLand in revised form August 4, 2001
Accepted for publication November 2, 2001 system [17]. This raises the interesting possibility that
the Fas-FasL interaction might be manipulated to inhibit 2002 by the International Society of Nephrology
1303
Wang et al: FasL cause leukocyte apoptosis1304
infiltrating inflammatory cells and fibroblasts in the inter- stimulated with 400 ng/mL recombinant human soluble
stitium in progressive chronic renal disease. The purpose FasL and 1 g/mL enhancer (gifts of Dr. Jurg Tschopp,
of this study was to examine whether TC could be trans- University of Lausanne, Switzerland) for 12 hours, and
fected with FasL, and whether TC transfected with FasL TC with 2 g/mL camptothecin (Sigma, Sydney, Austra-
could induce apoptosis of leukocytes in vitro without lia). The specificity of FasL-induced apoptosis was con-
causing TC apoptosis. firmed by adding a blocking antibody (10 g/mL) against
rat FasL (Santa Cruz Biotechnology, Inc., Santa Cruz,
CA, USA) to the cells in co-culture.METHODS
Insert co-culture. To study the effect of soluble FasLCells and cell culture
on leukocytes, confluent transfected TC were detached
For primary culture, TC were isolated and cultured with trypsin treatment and washed with 10% FCS me-
from normal male Wistar rats using isopycnic centrifuga- dium. A total of 106 /mL TC in 5% FCS were transferred
tion. Cells were grown in Dulbecco’s modified Eagle’s to 30-mm inserts (0.4 m pore diameter; Millipore-CM,
medium (DMEM) supplemented with epidermal growth Bedford, MA, USA). These inserts allow transfected
factor (EGF; 10 ng/mL) and insulin (5 mg/mL) in a 5% TC to be co-cultured with leukocytes without physical
CO2/95% O2 environment [18, 19]. Experiments were contact.
commenced after cells had reached confluence, which
Construction. The protein expression vectors (pTar-was usually between five to six days after the isolation
get) containing the cytomegalovirus (CMV) promoterprocedure. Leukocytes were separated from the spleen
were purchased from Promega (Promega, Australia). Toand peripheral blood of normal male Wistar rats by using
construct the rat (pTarget-rFasL) and human FasL-Lymphoprep (Pharmacia, Uppsala, Sweden) and centri-
expression plasmid (pTarget-hFasL), mononuclear cellsfuged at 400  g for 40 minutes. Cells were harvested
were separated from rat peripheral blood or human pe-at the interface and washed twice in phosphate-buffered
ripheral blood respectively. mRNA was extracted fromsaline (PBS). Leukocytes were cultured in RPMI me-
mononuclear cells after stimulation with phytohemag-dium (Biosciences, NSW, Australia) for 24 hours, and
glutinin (PHA; 10 ng/mL) and ConA (2 g/mL) for 12then activated by ConA (2 g/mL) for 12 hours. Jurkat
hours. DNA containing full coding region of the rat FasLcells, a human acute T-cell leukemia cell line, were grown
gene was amplified from rat mononuclear cells using thein RPMI medium supplemented with 10% fetal calf se-
PCR primers 5-CAAGACTGAGAGGAGGAAAC-3rum (FCS). NRK52E tubular epithelial cells, of rat ori-
gin, were cultured in DMEM containing 5% FCS. All and 5-TGGCATCCATGATAAAGAA-3. Similarly,
cells were cultured and maintained at 37C in 5% CO2/ full coding region of human FasL was amplified from
95%O2. NRK52E cells were used as TC in all experi- human mononuclear cells by using the polymerase chain
ments; TC in primary culture also were used in the exper- reaction (PCR) primers 5-CCTCTACAGGACTGAG
iment examining the effect of FasL on TC. AAGAAG-3 and 5-CAACATTCTCGGTGCCTGT
Co-culture. To study the effect on TC of FasL, TC in AA-3. PCR generated a 925 bp fragment of rat FasL
primary culture and transfected TC in which 80% of and a 963 bp of fragment of human FasL. The PCR
cells expressed FasL were detached and co-cultured in products were cloned into pTarget vectors, and se-
a ratio of 1:1. The mixed cells were cultured in FCS-free quenced to confirm that the inserts were vectored in the
medium for 24 hours and then exposed to lipopolysac- correct direction.
charide (LPS; 2.5 g/mL) and tumor necrosis factor- Transfections. NRK52E cells were seeded at a density
(TNF-; 3000 /mL) for 48 hours. of 3  105 cells/per well into six-well cell culture plates
To study the effect of FasL on Jurkat cells and leuko-
containing 1 mL DMEM without antibiotics. After 24
cytes, 106 transfected TC (effector cells) were incubated
hours, cells at 60% confluency were exposed to 1.5 gwith Jurkat cells or leukocytes (target cells), with fivefold
of plasmids (pTarget-rFasL or pTarget-hFasL) and 4 Lserial dilutions of target cells in six-well plates at varying
of lipofectamine (Life Technologies, Australia) per welleffector:target (E:T) ratios in 2 mL of RPMI medium
in DMEM without FCS. After five hours of transfection,for 12 hours at 37C in 5% CO2. The suspended cells
FCS was added into the medium to a final concentration(Jurkat cells or leukocytes) were collected and adherent
of 5%. Transfected TC were cultured until total conflu-cells (tubule cells) were detached for assessment. After
ence, and then G418 antibiotic (400 g/mL) added intoJurkat cells were co-cultured with TC, the cell types in
the medium. Transfected cells were selected by culturesupernatant were identified using CD45 staining (Phar-
with G418 for three weeks prior to commencing theMingen, San Diego, CA, USA). Of the suspended cells,
experiments. Similarly, NRK52E cells were transfected98.1  1.4% expressed CD45 indicating that most sus-
with plasmid (pTarget) without a FasL insert for use aspended cells were Jurkat cells and only a few were TC.
As a positive control for apoptosis, Jurkat cells were control in co-culture experiments.
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Fas and Fas ligand expression the target cells were resuspended in cold PBS on ice for
FACS analysis. At least 10,000 target cells from eachFlow cytometry. After culture, suspended cells were
sample were analyzed by FACS. Cells cultured alonecollected, and adherent cells were detached with 2.2
and without Annexin V-FITC staining were used as ammol/L ethylenediaminetetraacetic acid (EDTA), 0.2%
non Annexin V-FITC-binding control. The resultingbovine serum albumin (BSA) in PBS. Cells were washed
fluorescence histograms were corrected for nonspecificand resuspended in with PBS containing 0.2% BSA. To
staining by cumulative subtraction of the no Annexinstudy Fas expression, 5 105 cells from the same sample
V-FITC binding control to determine the percentage ofwere incubated with 1 g/mL anti-Fas antibody (Santa
Annexin V-FITC-binding positive cells (apoptotic cells).Cruz Biotechnology) and control rabbit IgG for 30 min-
Quantitation of cytotoxicity was determined by the per-utes at 4C, followed by incubation with 1:100 FITC-
centage of apoptotic target cells scored by FACS. Eachrabbit-anti-rabbit IgG for 30 minutes at 4C. To study
test was performed in triplicate in three separate experi-intracellular Fas ligand expression, 5  105 cells were
ments.fixed in 2% glutaraldehyde/PBS, washed in PBS, and
In situ cell death detection (TUNEL method). Cellpermeabilized in PBS containing 0.1% Triton X-100,
apoptosis was also assessed using in situ cell death detec-2% BSA and 1% goat serum for 30 minutes at room
tion kit, Fluorescein (Roche, Mannheim, Germany).temperature. Thereafter, cells were incubated with 1
Briefly, after washing with PBS, cells were fixed in 4%mg/mL polyclonal anti-Fas ligand antibody in PBS con-
paraformaldehyde solution for one hour and permeabil-taining 0.1% Triton X-100 and 0.2% BSA for 60 minutes,
ized with permeabilization solution for two minutes onfollowed by incubation with 1:100 FITC-goat anti-rabbit
ice. Then, cells were incubated with TUNEL reactionIgG for 60 minutes. Control samples were stained with
mixture for 60 minutes at 37C. After washing, cells werean anti-FasL antibody (Santa Cruz Biotechnology) that
analyzed by FACS.had been previously incubated with a control Fas ligand
The assays were evaluated in a side-to-side compari-peptide or with non-immune rabbit lgG. Cells were then
son. Apoptosis as detected by Annexin V and TUNEL
analyzed on a FACS.
methods was highly correlated (r 	 0.9891). Annexin V
Dead cells and debris were excluded from analysis by staining is more sensitive than TUNEL, with the advan-
selective gating based on anterior and right angle scatter. tage of being able to detect early stage apoptosis, which is
At least 10,000 events were collected for each sample, consistent with previously published results [21]. Further
and data were displayed on a logarithmic scale of increas- apoptosis studies were therefore performed mostly using
ing green-fluorescence intensity. Fluorescence of cells the Annexin V method.
was calculated using LYSIS II software (Becton Dickin-
son). Mean cell fluorescence obtained with the control Statistical analysis
IgG was subtracted from that obtained with the anti-Fas The results are expressed as the mean  SD, and
antibody. Data are expressed as the fold-increase over statistical significance of differences within the groups
control cells grown in 10% FCS RPMI. and among groups was determined by one way ANOVA.
Reverse transcription-polymerase chain reaction (RT- A P value less than 0.05 was considered significant.
PCR). Total RNA was isolated from TC transfected
with FasL by TRI reagent (Sigma Aldrich Pty Ltd, Aus-
RESULTStralia) and reverse-transcribed into cDNA by random
priming. Polymerase chain reaction (PCR) for FasL am- FasL expression of transfected tubule cells
plification was performed for 30 cycles with a two-step NRK52E cells were transfected with a construct of
amplification (94C for 20 sec and 60C for 80 sec), using rFasL or hFasL containing a CMV promoter. After
the following primers: 5-GCAGCAGCCCGTGAAT transfection, FasL expression in TC transfected with
TAC-3 and 5-GCTTAGGGGCTGGCTGTT-3. PCR FasL vectors was increased (32  3.8%), and further
generated a 612-bp nucleotide for rFasL cDNA and a increased after selection by the antibiotic G480. How-
822bp for the housekeeping gene GAPDH. PCR prod- ever, Fas expression in TC transfected with FasL was
ucts were analyzed on an ethidium bromide-stained 1.2% not increased (Fig. 1).
agarose gel. FasL mRNA expression of transfected TC was also
Detection of apoptosis using Annexin V staining [20]. examined by RT-PCR. NRK52E cells transfected with
The collected target cells were washed in PBS, resus- rFasL showed high levels of FasL expression, as com-
pended in Annexin binding buffer (Clontech, Palo Alto, pared to low levels of rFasL expression in untransfected
CA, USA), and stained with Annexin V-fluorescein iso- cells (Fig. 2).
thiocyanate (FITC) for five minutes at room temperature The effect of exposure to LPS or TNF- on apoptosis
in the dark using the ApoAler Annexin V Apoptosis was examined in transfected TC by Annexin V binding.
There was no significant increase of apoptosis in TCKit (Clontech). The staining solution was removed and
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Fig. 1. Efficiency of FasL transfection and se-
lection by the antibiotic G480. (A) FasL and
(B) Fas expression in (1) untransfected TC,
(2) TC transfected with rFasL, and (3) TC
transfected with hFasL. FasL expression was
increased, but Fas expression was not changed
after transfection and selection.
detection of apoptosis by Annexin V versus TUNEL
methods (Fig. 5B). Apoptosis of Jurkat cells as assessed
by Annexin V, was increased ninefold after co-culture
with TC transfected with hFasL (67  12.1% vs. 6.7 
1.8%, P  0.01), and eightfold with TC transfected with
rFasL (60.1  8.8% vs. 6.7  1.8%, P  0.01; Fig. 6A).
However, TC transfected with hFasL or rFasL did not
show increased apoptosis after co-culture with JurkatFig. 2. Reverse transcription-polymerase chain reaction (RT-PCR)
showing semiquantitative FasL mRNA levels relative to GAPDH cells (Fig. 6B).
mRNA levels: low levels in untransfected TC (lanes 1 and 2) and higher
levels in TC transfected with rFasL (lanes 3 and 4). This figure is TC transfected with FasL induce leukocyte apoptosis
representative of experiments repeated three times.
Leukocytes from peripheral blood and spleen were
activated by ConA (2g/mL) for 12 hours. After stimula-
tion, 34.0  5.6% of leukocytes expressed Fas on their
transfected with FasL following exposure to LPS or cell surface (Fig. 4). Co-culture was used to examine the
TNF- for 48 hours (Fig. 3A). Similarly, exposure to effects of cell surface FasL of transfected tubule cells on
LPS or TNF- for 48 hours of transfected TC co-cultured leukocyte apoptosis. Apoptosis of activated leukocytes
with untransfected TC did not increase apoptosis in ei- was increased by coculture with TC transfected with
ther cell type (Fig. 3B), despite of an increase in FasL rFasL (26.8  4.9 vs. 6.7  2.0% with untransfected TC,
expression by TC (Fig. 3C). Stimulation of FasL expres- and vs. 8.6%  3.1% with TC transfected with pTarget
sion [for example, with interferon-
 (IFN-
)] on leuko- vector). Insert co-culture was used to examine the effects
cytes or Jurkat cells did not increase their apoptosis (data of soluble FasL secreted from transfected tubule cells
not shown). on leukocyte apoptosis. Increased apoptosis was found
in activated leukocytes in insert co-culture with TC trans-
Tubule cells transfected with FasL induce fected with rFasL compared to both untransfected TC
Jurkat cell apoptosis and TC transfected with pTarget vector without rFasL
Jurkat cells are known to express Fas on their cell (18.2  4.4% vs. 5.8  2.3% with untransfected TC,
surface [22]. The level of Fas expression was examined and vs. 8.2  3.6% with pTarget PC). The increase of
in Jurkat cells. 78.5  15% percent of Jurkat cells ex- leukocyte apoptosis was blocked by anti-FasL antibody
pressed Fas (Fig. 4). After Jurkat cells were co-cultured in both co-culture and insert culture (Fig. 7). No in-
with TC transfected with rFasL for 1, 6 and 12 hours, creased apoptosis was detected in TC transfected with
apoptosis was examined by both Annexin V and TUNEL FasL after co-culture or cell-insert culture with activated
leukocytes.methods (Fig. 5A). There was a strong correlation in the
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Fig. 3. (A) Apoptosis of tubule cells (TC) transfected with rFasL or
hFasL as assessed by Annexin V binding. There was no significant
increase of apoptosis in transfected TC following exposure to lipopoly-
saccharide (LPS 2.5 g/mL) or tumor necrosis factor- (TNF- 3000
U/mL) for 48 hours). Symbols are: ( ) TC; () rFASL TC; ( ) bFasL
TC. N 	 12 for each bar. (B) Apoptosis of TC in primary culture
and mixed cells from primary culture of TC ( ) and TC (NRK52E)
transfected with rFasL (in ratio of 1:1; ) following exposure to LPS
(2.5 g/mL) or TNF- (3000 U/mL) for 48 hours. N 	 12 for each bar.
(C ) FasL expression of TC in primary culture following exposure to
LPS (2.5 g/mL), TNF- (3000 U/mL) or PMA (10 g)  ionomycin
(500 ng/mL) for 48 hours. N 	 12 for each bar; *P  0.01 and **P 
0.001 vs. unstimulated cells.
DISCUSSION apoptosis of transfected or untransfected TC themselves,
even when stimulated by LPS and TNF-. However, TCAlthough the Fas/FasL interaction has been utilized
transfected with FasL increased apoptosis of Jurkat cellsas a potential therapeutic approach for cancer and au-
or activated leukocytes. None of the TC cells transfectedtoimmune disorders [10, 11], and for manipulating
with FasL showed apoptosis in co-culture with eitherinflammation in other systems [12, 13], the utility of mod-
Jurkat cells or leukocytes.ulating the Fas/FasL pathway to prevent renal inflam-
Fas, a 45-kD type I membrane protein, belongs to themation and fibrosis has not been tested previously. In
tumor necrosis family, and is expressed in cells of mostthese studies, we demonstrated that tubular cell transfec-
tion with either rat FasL or human FasL had no effect on organs, including the thymus, liver, heart and kidney. In
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Fig. 4. Expression of Fas in Jurkat cells and
leukocytes. (A) Unstimulated leukocytes, (B)
leukocytes after stimulation for 12 hours with
2 g/mL ConA, and (C) Jurkat cells without
any stimulation. This figure is representative
of experiments repeated three times.
In these studies, an attempt has been made to manipu-
late Fas/FasL interaction to eliminate leukocytes. For
this to have any clinical utility, it is critical that the ef-
fector cells (tubule cells) do not undergo apoptosis after
transfection with FasL and during interaction between
TC and leukocytes and fibroblasts. Fas expression has
been demonstrated in human renal tubular epithelial
cells, but interaction between Fas and FasL did not in-
duce apoptosis in TC [14], indicating that apoptosis of TC
in that situation was Fas-independent. However, other
studies have shown that LPS or TNF- increased Fas
expression as well as apoptosis in TC [26, 27], suggesting
that Fas/FasL could be involved in the apoptosis of TC.
Schelling et al found that baseline-expression of Fas by
TC was insufficient for functional Fas-FasL interaction
between TC [28]. However, induction of Fas expression
by cytokines was able to produce apoptosis in various
tubule cell lines [29]. The occurrence of apoptosis was
thought to be due to the interaction of TC Fas with
membrane FasL from adjacent TC [28]. In our present
study, TC transfected to a high level with FasL were
stimulated with LPS or TNF- for 48 hours, and showed
no increased apoptosis. Further, TC in primary culture
mixed with TC transfected with FasL and exposed toFig. 5. Comparison of assessment of apoptosis by Annexin V versus
TUNEL methods. (A) After Jurkat cells were co-cultured with TC LPS or TNF- for 48 hours in a non-serum medium, also
transfected with rFasL for 1, 6 and 12 hours, apoptosis was assessed showed no increased apoptosis in either cell type, evenby both Annexin V ( ) and TUNEL () methods. (B) There was a
though primary cultured TC could be stimulated to ex-strong correlation in the detection of apoptosis by Annexin V versus
TUNEL method (y 	 0.8497x  2.3593, R2 	 0.9891). press endogenous FasL. The discrepancy between these
data and other studies could be due to species differences
(rat vs. mouse and human), cell origin (TC in primary
culture vs. cell lines) and culture conditions (with serum-contrast, FasL, a 40 kD type II membrane protein, is
containing medium vs. serum-free medium). However,expressed in a much more restricted number of tissues,
our results suggest highly that TC undergoing apoptosisincluding activated T cells and natural killer cells and
do not depend, at least in rats, on Fas/FasL.in immune privileged sites such as the eye and testis.
Interactions between TC and leukocytes are complex.Moreover, it has been demonstrated that FasL in certain
A conventional paradigm is that the TC, expressing Fastissues such as testis or cornea plays an important role
and under the influence of activated T cells, could under-in creating immune privilege [23]. Induction of FasL on
go apoptosis by Fas/FasL- or perforin/granzyme B-basedT cells and T cell lines results in cell death by apoptosis.
cytotoxicity in chronic renal disease or in renal allograftActivation of Fas via soluble FasL or anti-Fas antibodies
rejection [30, 31]. In our present study, the co-cultureresults in apoptotic cell death in both lymphoid and cer-
of activated leukocytes with TC showed no increase intain nonlymphoid tissues [24]. FasL has been shown to
apoptosis in either resting TC or TC transfected withprolong pancreatic islet allograft survival when ex-
pressed on co-transplanted syngeneic myoblasts [25]. FasL. These data demonstrate that under the conditions
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Fig. 6. Cellular apoptosis assessed by Annexin V binding after 12 hours co-culture of Jurkat cells with TC. (A) Apoptosis of Jurkat cells with (1)
media only, (2) recombinant FasL, (3) untransfected TC, (4) TC transfected with hFasL, or (5) TC transfected with rFasL. (B) Apoptosis of TC
with (1) untransfected TC with media only, (2) with camptothecin (2 g/mL), (3) with Jurkat cells, (4) TC transfected with hFasL plus Jurkat cells,
and (5) TC transfected with rFasL plus Jurkat cells. TC transfected with either hFasL or rFasL increased apoptosis of Jurkat cells (A) but not
TC themselves (B). These figures are representative of experiments repeated five times.
described, TC are resistant to T cell-mediated apoptosis.
On the other hand, baseline FasL expression in normal
TC was also not capable of producing apoptosis of acti-
vated T cells, via a Fas/FasL reaction. TC transfected
with FasL increased Jurkat cell and leukocyte apoptosis.
This finding demonstrated the possibility that TC trans-
fected with FasL could act as effector cells to eliminate
leukocytes in chronic diseases without themselves under-
going self-destruction.
There are two types of FasL: membrane FasL and
soluble FasL. It has been demonstrated that soluble FasL
is released from the cell surface of macrophages and T
cells under metalloproteinase digestion. Recently, solu-
ble FasL was reported to be generated from various TC
lines as well [28]. TC with high level FasL expression
could mediate apoptosis of Fas-expressing leukocytes
and fibroblasts by direct contact in pathologic situations
[32]. However, it is also important to explore the possibil-
ity that TC could send death signals by soluble FasL to
distant interstitial cells separated from TC by tubular
basement membrane, thickened in chronic renal dis-
eases. In the present studies, TC transfected with FasL
on one side of a membrane-separated chamber were
able to increase the apoptosis of leukocytes on another
side of membrane, although the efficiency of this interac- Fig. 7. Apoptosis of leukocytes after 12 hours co-culture () or insert
tion was less than that of direct contact. culture ( ) with either media only, untransfected TC, pTarget TC (TC
transfected with pTarget vector but no FasL insert), rFasL TC, or rFasLAlthough TC transfected with FasL were observed to
TC  anti-FasL antibody. Increased apoptosis was seen in rFasL cellsdeliver death signals to leukocytes in vitro, the effects compared to each of the other cell types (*P  0.01, N 	 12 for each
bar) and this increased apoptosis was blocked by anti-FasL antibody.of transfection of TC with FasL are likely to be complex
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